CoChat
Sign Up
Cited by 228Viral Infections and Immunology ResearchCardiac Fibrosis and RemodelingOcular Diseases and Behçet’s Syndrome

The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.

Cardiac Autoimmunity: Myocarditis

Open access
Bracamonte-Baran, William, Čiháková, Daniela·2017·Advances in Experimental Medicine and Biology
DOI 10.1007/978-3-319-57613-8_10PMC PMC5706653
Open this paper in CoChat — free account

Abstract

Myocarditis is the inflammation of the muscle tissues of the heart (myocardium). After a pathologic cardiac-specific inflammatory process, it may progress to chronic damage and dilated cardiomyopathy. The latter is characterized by systolic dysfunction, whose clinical correlate is heart failure. Nevertheless, other acute complications may arise as consequence of tissue damage and electrophysiologic disturbances. Different etiologies are involved in triggering myocarditis. In some cases, such as giant cell myocarditis or eosinophilic necrotizing myocarditis, it is an autoimmune process. Several factors predispose the development of autoimmune myocarditis such as systemic/local primary autoimmunity, viral infection, HLA and gender bias, exposure of cryptic antigens, mimicry, and deficient thymic training/Treg induction. Once the anti-myocardium autoimmune process is triggered, several components of the immune response orchestrate a sustained attack toward myocardial tissues with particular timing and immunopathogenic features. Innate response mediated by monocytes/macrophages, neutrophils, and eosinophils parallels the adaptive response, playing a final effector role and not only a priming function. Stromal cells like fibroblast are also involved in the process through specific cytokines. Furthermore, adaptive T cell responses have anti-paradigmatic features, as Th17 response is dispensable for acute myocarditis but is the main driver of the process leading to dilated cardiomyopathy. Humoral response, thought to be a bystander, is important in the appearance of late-stage hemodynamic complications. The complexity of that process, as well as the unspecific and variable clinical presentation, had generated difficulties for diagnosis and treatment, which remain suboptimal. In this chapter, we will discuss the most relevant immunopathogenic findings from a basic science and clinical perspective.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/978-3-319-57613-8_10

Cites

167 of 167 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Cited by

Sorted by citations

See all 228

Related

See all

Metadata

Authors
Bracamonte-Baran, W., & Čiháková, D.
Affiliations
Johns Hopkins University (US)
Corresponding author
Čiháková, Daniela
ORCID
Čiháková, Daniela
Venue
Advances in Experimental Medicine and Biology
Publisher
Springer International Publishing
Published
2017
Volume
1003
Pages
187-221
ISSN
  • 0065-2598 (ISSN-L)
  • 2214-8019
DOI
10.1007/978-3-319-57613-8_10
PMC
PMC5706653
OpenAlex
W2727000909
Cited by
228
References
167
Citations by year
2026: 12 · 2025: 26 · 2024: 28 · 2023: 43 · 2022: 32 · 2021: 41 · 2020: 22 · 2019: 12 · 2018: 11 · 2017: 1
FWCI
73.98
Type
book chapter
Language
en
Open access
Licence
www.springer.com/tdm (unspecified)
Locations
  • Advances in experimental medicine and biology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Heart, Lung, and Blood Institute (R01HL113008, R01HL118183)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords
autoimmune myocarditis, dilated cardiomyopathy, giant cell myocarditis, Th17 response, Treg induction, HLA, viral infection, antigen mimicry, innate immune response, humoral immune response, heart failure, immunopathogenesis
MeSH terms
Animals, Autoimmune Diseases, Disease Models, Animal, Humans, Immunosuppressive Agents, Myocarditis, Myocardium, Prognosis, Risk Factors, Signal Transduction, Autoimmunity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review